Skip to main content
. Author manuscript; available in PMC: 2017 Nov 30.
Published in final edited form as: Obesity (Silver Spring). 2017 May 30;25(7):1284–1291. doi: 10.1002/oby.21875

Table 4.

Linear regression of log PAT or log PAT/SAT ratio on GIR

Model Log PAT Log PAT/SAT
Males (N=36) Females (N=47) p for log (N=83) p for log
β (±SE)*, p-value β (±SE)*, p-value PAT* sex β (±SE)*, p-value PAT/SAT* sex
Model 1 −2.62 (±1.27), 0.051 0.05 (±1.05), 0.962 0.218 −1.03 (±0.68), 0.136 0.782
Model 2 −1.03 (±1.46), 0.485 −0.49 (±1.30), 0.707 0.201 −1.35 (±0.70), 0.057 0.835
Model 3§ −1.33 (±1.78), 0.462 1.48 (±1.46), 0.320 0.111 −0.96 (±0.74), 0.200 0.807
Model 4|| −0.18 (±2.38), 0.940 3.36 (±1.96), 0.097 0.055 −2.08 (±1.03), 0.047 0.768

Abbreviations: PAT, pericardial adipose tissue; SAT, subcutaneous adipose tissue; GIR, glucose infusion rate; BMI, body mass index; VAT, visceral adipose tissue; LDL, low-density lipoprotein

*

Per 1 SD

Adjusted for diabetes, race, age, systolic blood pressure, LDL, log triglycerides, on blood pressure and lipid lowering medication, percent of energy from fats and carbohydrates, and square-root transformed minutes of moderate intensity-equivalent activity weekly; additionally adjusted for sex in log PAT/SAT ratio models

Adjusted for variables in Model 1 + BMI

§

Adjusted for variables in Model 2 + VAT

||

Adjusted for variables in Model 3 + log PAT/SAT ratio or log PAT, respectively